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Abstract
In this study, we intend to solve a mutual
information problem in interacting molecules
of any type, such as proteins, nucleic acids,
and small molecules. Using machine learn-
ing techniques, we accurately predict pair-
wise interactions, which can be of medical
and biological importance. Graphs are are
useful in this problem for their generality to
all types of molecules, due to the inherent
association of atoms through atomic bonds.
Subgraphs can represent different molecular
domains. These domains can be biologically
significant as most molecules only have por-
tions that are of functional significance and
can interact with other domains. Thus, we
use subgraphs as features in different machine
learning algorithms to predict if two drugs in-
teract and predict potential single molecule
effects.
Introduction
In drug discovery, each new molecular entity costs
on average $1.8 billion (Paul et al., 2010). Finding
drug candidates from over 50 million small molecules
available in open access databases (Roy et al., 2010),
such as PubChem (Bolton et al., 2008) and ChEMBL
(Gaulton et al., 2012), have the potential to save both
lives and money.
Over 90,000 proteins (Gonza`lez-Porta et al.,
2013) and 40,000 small molecule metabolites
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(Wishart et al., 2013) naturally occur in human
cells. Function is often characterized by interac-
tions, e.g. KEGG (Kanehisa & Goto, 2000) defines
functional biological pathways in terms of pairwise
molecular interactions, while DrugBank (Law et al.,
2014) defines drug-drug interactions that influence
dosage and functional drug-target interactions.
Machine learning efficiently finds promising drug
candidates, reducing drug discovery cost by only
taking drugs to in vitro tests that are predicted
to selectively interact with the molecule of interest
(Fukunishi, 2009) (Khandelwal et al., 2008).
Problem Definition and Methods
In our first aim, we benchmark our methods on a mu-
tagenicity prediction dataset. In our second aim, we
predict the interactions of interest.
Task Definition
Aim 1 Predict mutagenicity based on subgraphs.
Mutagenicity is the ability of a compound to
change genetic materials. If a drug is mutagenic,
it cannot be safely consumed by a patient, even
with predicted drug-target interaction.
Aim 2 Predict drug interactions based on their sub-
graphs. We consider both small molecules and
proteins for interactions. An interaction occurs if
dosage must be adjusted, due to both drugs being
present in a patient (Law et al., 2014).
Algorithms and Methods
Features consist of subgraph counts derived from the
dataset. Subgraphs to be included in the feature set
depended on parameter choices of height and distance.
Height describes the max distance between any two
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nodes in the subgraph. Distance is the max number of
nodes away two subgraphs are from each other in the
full graph.
Rather than use only subgraphs at a single height,
we subgraphs for multiple heights up to a maximum
height (Figure 1). We let subgraph s at height h
among atoms A be defined as:
s(h, a ∈ A,A) = ∀b ∈ A, d(a, b) ≤ h (1)
where d is shortest path distance. Let c be the count
of occurrences of a subgraph s in a molecule M having
atoms A:
c(h,A) =
∑
a∈A
I(s(h, a,A)) (2)
where I is the indicator function. We let the feature
set F of all counts c at desired heights H fully describe
the molecule M having atoms A:
F (H,A ∈M) = ∀h ∈ H, {c1(h,A), ..., cn=|F |(h,A)}
(3)
For mutagenicity prediction, we considered two kinds
of feature sets:
1. Similar to prior published methods
(Costa & Grave, 2010), we considered a pair
of subgraphs separated by a distance as a feature.
2. More simply, we considered subgraphs at desired
heights as features, rather than subgraph pairs.
For drug interaction prediction, our method reduces
computational cost in two ways:
1. Consider only a subset of heights up to a maxi-
mum height, not all such heights, and
2. do not consider pairs of subgraphs separated by a
distance as features.
We also implemented the two kernels from Costa and
Grave (2010) and Faulon et al. (2008) and generated
kernelized and un-kernelized data (Costa & Grave,
2010) (Faulon et al., 2008). We were unsure as to
the possibility of implementing a kernel trick into all
of the ensemble classifiers we chose to use, so we had to
generate kernelized input data to use in our ensemble
classifiers. Thus used three types of datasets:
1. Subgraphs or subgraph pair data.
2. Data after cosine similarity kernel applied, like
Faulon 2008.
Figure 1. Subgraph heights 0, 1, and 2 in dark, light,
and pale green regions, respectively
3. Data after NSPDK kernel applied, like Costa and
Grave 2010.
We tested convolutional neural network (CNN), ran-
dom forest (RF), multilayer perceptron (MLP), and
support vector machine (SVM) algorithms. Random
forest performed best.
Random Forest
Random forests were generated using Scikit-learns
RandomForestClassifier (Pedregosa et al., 2011).
Random forest subsamples the training data and fea-
ture set to build each decision tree in the forest. Each
decision tree was allowed to grow fully and both en-
tropy and gini impurity were tried as splitting crite-
ria. 100 decision trees were used to make the ran-
dom forest. This particular implementation averages
the probabilistic prediction of all decision trees in the
forest instead of letting each decision tree vote for a
classification.
Support Vector Machine
We used SVMlight on all dataset types with all com-
binations of settings:
1. Linear hyperplane (svm learn -t 0) or radial ba-
sis function kernel (svm learn -t 2) classifier.
2. Negative example ratio correction enabled or dis-
abled (svm learn -j 0.8). In the Bursi data,
there are 0.8 negative examples for every positive
example.
3. Sum of slacks, C, of 1, 10, and 100 (svm learn -c
1).
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Table 1. Machine learning algorithm performance: area under ROC and validation set accuracy. Each algorithm’s perfor-
mance is noted for the top one or two height/distance formats parsed from the Bursi dataset. RF metrics listed as mean
± stdev. MLP and CNN metrics listed as (min,mean±stdev,max). CNN processes each data row as three partitions,
each partition being one third of the original row, the first third being subgraphs with the fewest atoms, the last third
being subgraphs with the most atoms. This CNN connects the first partition to the first hidden node, the first and second
partitions to the second hidden node, the second and third partitions to the third hidden node, and the third partition to
the fourth hidden node. For MLP, 3→1 topology means there are three hidden nodes and one output node. For RF, 100
trees were in the forest, where each tree was allowed to grow out fully. Kernels were not used for any algorithm reported
in this table.
Algo Topology Height/Distance AUROC Validation Acc Trials
RF data→100tr H=1 0.89739±0.024 0.82639±0.011 100
RF data→100tr H=[0-3] D=[0-5] 0.89486±0.007 0.82022±0.009 100
CNN 3(data⁄3)→4→1 H=[0-3] D=[0-5] - (0.78701,0.79085±0.004,0.79609) 4
MLP data→3→1 H=2 - (0.60545,0.76383±0.044,0.81564) 40
MLP data→3→1 H=[0-3] D=[0-5] - (0.55307,0.72895±0.108,0.82332) 7
Multilayer Perceptron
We implemented a multilayer perceptron (Mitchell,
1997):
1. One output node and three hidden nodes.
2. Weight updates through backpropagation and
momentum.
3. Voted and unvoted perceptrons.
4. Annealed learning rate.
5. Convergence when validation error did not im-
prove after one full iteration through data.
6. For online learning, not batch learning.
Convolutional Neural Network
We implemented a convolutional neural network
(LeCun et al., 1998):
1. One output node and four hidden nodes.
2. Data split into thirds by subgraph mass, e.g.
when sorting a rows X subgraphs by lowest to
highest mass, the X⁄3 subgraphs are grouped as the
lightest third, the next X⁄3 subgraphs are grouped
into the middle third, and the next X⁄3 subgraphs
are grouped into the heaviest third.
3. Other settings identical to MLP.
Experimental Evaluation
Methodology
To allow for direct comparison to prior methods
(Costa & Grave, 2010) (Faulon et al., 2008), we opti-
mized for area under the receiver operator curve (AU-
ROC) instead of accuracy. AUROC is a measure of
the effect of changing the discrimination threshold of
a binary classifier. It is calculated by plotting the true
positive rate against the false positive rate over many
different threshold values, and then calculate the area
under said curve. AUROC and accuracy are different
because accuracy can be thought of as a measurement
at one threshold value. For completeness, we report
training and validation accuracy. We used both 10-
fold cross-validation and 100 iterations of randomly
splitting the dataset such that 2⁄3 makes up a training
set and 1⁄3 makes up a validation set. We also compare
different methods using two-sample un-pooled t-tests
with a significance threshold (alpha) of 0.05.
Mutagenicity Prediction
We computed features at a variety of feature heights
(1-12) and distances (0-20). Algorithms we tested in-
clude RF, MLP, CNN, and SVM. Statistical signifi-
cances were determined using un-pooled two-sample
t-tests.
We wrote a Bursi data parser that processes the
data in two ways: (1) decomposing a molecule into
subgraphs (Faulon et al., 2008), and (2) decomposing
a molecule into subgraph pairs separated at a dis-
tance (Costa & Grave, 2010). Though in prior work
(Costa & Grave, 2010), we forwent PTC and NTP
HIV analyses for two reasons: (1) their categorical
classifications are more complex than the binary clas-
sifications in Bursi, and (2) our motivation to focus on
interaction prediction for the public good.
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Figure 2. Comparison Between Methods for Muta-
genicity
Interaction Prediction
Means and standard deviations of AUROC and accu-
racies were established using 10-fold cross-validation.
We wrote a DrugBank data parser that decomposes a
molecule into subgraphs. For drugs or targets listed in
DrugBank where SMILES or protein sequence was not
provided, the parser fetches the missing information
from PubChem or UniProt, respectively. PubChem
results where the chemical name does not match the
DrugBank-provided name are rejected. We took two
samples from DrugBank for evaluation: (1) 37 positive
training examples and 39 negative training examples,
and (2) 131 positive training examples and 140 nega-
tive training examples.
Results
Among all the algorithms that we tried, random for-
est had the best result out of the ensemble classifiers
(Table 1) (Figure 2). Random forest did significantly
better than the other ensemble classifiers (from two-
sample unpooled t-tests). A more detailed analysis of
the random forest method showed that using height
one gave us the best results (Figure 4). Also the two
different splitting criteria did not produce any sig-
nificant changes (from two-sample unpooled t-tests).
We compared random forest and previously published
methods for mutagenicity prediction, and found that
Figure 3. Comparison Between Methods for Muta-
genicity Prediction
random forest on un-kernelized height one and dis-
tance zero data did as well as or better than four
previously published kernel-based methods (Figure 3).
However random forest is not significantly better than
any of the previously published methods (from two-
sample unpooled t-tests). We also compared our ran-
dom forest method against previously published meth-
ods for molecular interaction prediction from Drug-
Bank data. The drug-target interactions with random
forest had 94.5% AUROC and 86.1% validation ac-
curacy (Figure 5) while a previously published ker-
nel based method got 74% AUROC and 67.5% accu-
racy when they optimized for AUROC (Faulon et al.,
2008). We cannot establish if our result is statistically
significant because the other method did not report a
standard deviation. However we believe 20% differ-
ence probably is statistically significant.
Discussion
Random forest on un-kernelized data does as well as
or better than four previously published kernel-based
methods in prediction mutagenicity. We hypothesize
that this may be due to small local rules (such as “do-
main A with domain B is always mutagenic”) in chem-
istry that are not well approximated in the full dataset.
Random forest uses subsets of training data and sub-
sets of features to build the decision trees, which is
more likely to capture these types of rules. The ran-
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Figure 4. Random Forest Results
Figure 5. Comparison Between Methods for Molec-
ular Interaction Prediction from DrugBank
dom forest implementation we used allows each deci-
sion tree to grow out fully, so possible features that can
be used as splitting criteria depends on the subset of
features used to generate each tree. This allows each
tree to try to approximate potentially different small
biological/chemistry rules. Height 1 and distance 0
produced the best results, which may seem counter-
intuitive at first because the subgraphs themselves do
not contain much information on the molecules topol-
ogy. However, structure of individual trees may imply
neighboring structures. Molecules are 3-dimensional
structures, but we parsed and used their 2-dimensional
structure so neighboring subgraphs in 3-dimensional
space may not be captured with subgraph representa-
tion alone. Every splitting criteria in each tree of the
random forest is a feature representing the count of a
small subgraph. Therefore, series of splits might rep-
resent a local structure found in the whole molecule.
Another seemingly odd result we encountered is that
using kernelized data did not help the AUROC or accu-
racies of our ensemble classifiers. The kernels we used
were designed for use in SVMs and may not translate
well into ensemble classifiers.
Drug-target interactions with random forest gets 94.5%
AUROC and 86.1% validation accuracy while a previ-
ously published kernel based method got 74% AUROC
and 67.5% accuracy. The other method used slightly
different data that we tried to replicate as best as pos-
sible. We hypothesize that this may be due to small
local rules (such as “domain A interacts with domain
B) in chemistry that are not well approximated in the
full dataset. Reasons outlined in the above as to why
we believe random forest did better than previously
published methods and why kernelizing the data did
not help also applies here to molecular interaction pre-
diction.
Related Work
Costa and Grave (2010) did not predict drug-target
interactions, but used all feature heights up to a max-
imum height and all distances separating subgraph
pairs up to a maximum distance (Costa & Grave,
2010). The authors achieved 91.7% AUROC for the
graphs not augmented with functional groups from
organic chemistry, improving to 92.0% AUROC with
augmentation. Parsing all features for all small and
large molecules in DrugBank was not computationally
feasible in terms of time or memory.
Faulon et al. (2008) predicted drug-target interactions
using support vector machines and a cosine similarity
kernel, achieving 74% AUROC and 67.5% accuracy
when optimizing for AUROC (Faulon et al., 2008).
The authors used features at a single height for small
molecules and a single height for proteins, rather than
multiple heights.
Yu et al. (2012) also predicted drug-target interac-
tions using random forest classifiers and achieved an
average 89.65% AUROC (Yu et al., 2012). However,
the feature set they used consisted of chemical and pro-
tein descriptors instead of subgraphs as in our project.
Their dataset also is different than ours, but it is in-
teresting to note that random forest has been applied
to similar problem setups and has done well.
Predicting Drug Interactions and Mutagenicity with Ensemble Classifiers on Subgraphs of Molecules
Future Work
1. We kernelized the data without considering inter-
action terms between features, so the next step is
to kernelize the expanded feature set as well as
trying to use the un-kernelized expanded feature
set.
2. Try reducing the feature set based on results from
a random forest before using other ensemble clas-
sifiers and kernels. Random forests can be used to
assign variable importance to features. By using
a reduced feature set, we might be able to more
accurately capture small rules and potentially in-
crease the accuracy of all the methods we tried in
this project.
3. Use augmented graphs with annotated nodes and
edges, using annotations such as domain family.
Costa and Grave (2010) found a small improve-
ment to their AUROC when using an augmented
graph (Costa & Grave, 2010).
4. Take a larger sample from DrugBank. We are cur-
rently parsing 20,000+ positive training examples.
5. Continue developing ensemble classifier-based
methods with kernels.
Conclusion
Random forest performed well in mutagenicity predic-
tion and molecular interaction prediction compared to
previously published methods. We show that random
forest performs better than other ensemble classifiers
in mutagenicity prediction and that parameter settings
of height one, distance 0, and un-kernelized data pro-
duced the best results. Our random forest implemen-
tation did not do significantly better than previously
published methods we found, but in terms of mean
AUROC ± one standard deviation, we did as well or
better than 4 out of 6 other methods (Costa & Grave,
2010). Our random forest implementation for molec-
ular interaction prediction did around 20% better in
terms of AUROC and accuracy than a previously pub-
lished method (Faulon et al., 2008).
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